Skip to content

A 12 weeks, randomized, double-blind, placebo-controlled human trial of Aronia and Red Ginseng mixture on improvement of Hyperglycemia

A 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Aronia and Red Ginseng mixture on improvement of Hyperglycemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0005830
Enrollment
80
Registered
2021-01-27
Start date
2019-12-16
Completion date
Unknown
Last updated
2021-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : • Aronia and Red Ginseng mixture group: Twice a day, 1 tablet once, after breakfast and dinner, for 12 weeks(8 g/day, 8 g/day for Aronia and Red Ginseng mixture) • Placebo group:

Sponsors

Woosuk University Korean Medicine Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Males and females aged over 19 years and under 70 years at the screening examination 2) Fasting blood glucose=100 mg/dL and <140 mg/dL 3) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions

Exclusion criteria

Exclusion criteria: 1) Patients who need care of diabetes at the screening examination. 2) Patients who take medicine for glucose and intake health functional food within 3 months prior to the screening examination. 3) Patients with a history of medicine or alcohol abuse 4) Patients who have participated in other clinical trials within 3 months prior to the screening examination

Design outcomes

Primary

MeasureTime frame
fasting glucose;postprandial glucose

Secondary

MeasureTime frame
Insulin;HbA1c(Hemoglobin A1c);lipid profile;C-peptide

Countries

Korea, Republic of

Contacts

Public ContactSoo jung Park

Woosuk University Korean Medicine Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026